Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
TAG’s Research in Action Awards, November 19, will be virtual (and free!). Here’s how to join Sharon Stone and others.
Experts analyze oral arguments in the GOP’s latest attempt to repeal Obamacare.
Culturally mindful educational programs may help Black people seek help earlier and throttle hep B incidence rates in these communities.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
Staff at the Australian quarantine hotel wrongly reused blood glucose tests on multiple individuals, but the contamination risk is very low.
Colleen O’Neill will lead the organization’s efforts against HIV, hepatitis C, homelessness and more.
The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
Twelve states have an adult obesity prevalence of 35% or more.
A flu shot can save lives and conserve medical resources for those fighting the coronavirus.
The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat.
The Arlington location is one of over 35 clinics in the South operated by CAN Community Health.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
Formerly a homeless person who used heroin, she advocated for New Yorkers affected by housing insecurity, drugs, HIV and hepatitis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.